Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
Middle East respiratory syndrome coronavirus (MERS-CoV) has infected at least 2040 patients and caused 712 deaths since its first appearance in 2012, yet neither pathogen-specific therapeutics nor approved vaccines are available. To address this need, we are developing a subunit recombinant protein...
| Príomhchruthaitheoirí: | , , , , , , , , , , , , , |
|---|---|
| Formáid: | Alt |
| Foilsithe / Cruthaithe: |
Elsevier
2018
|
| Ábhair: |